There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Inovio Pharmaceuticals
Tag: INO
H.C. Wainwright Remains a Buy on Inovio Pharmaceuticals
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Inovio Pharmaceuticals (NASDAQ: INO), with
Analysts Offer Insights on Healthcare Companies: Inovio Pharmaceuticals (NASDAQ: INO), Hologic (NASDAQ: HOLX) and Biolinerx (NASDAQ: BLRX)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inovio Pharmaceuticals
Inovio Pharmaceuticals Received its Third Buy in a Row
After H.C. Wainwright and Maxim Group assigned a Buy rating to Inovio Pharmaceuticals in the last month, the company received
Inovio Pharmaceuticals Received its Third Buy in a Row
After Maxim Group and H.C. Wainwright assigned a Buy rating to Inovio Pharmaceuticals in the last month, the company received
Inovio Pharmaceuticals Received its Third Buy in a Row
After Stifel Nicolaus and Maxim Group assigned a Buy rating to Inovio Pharmaceuticals in the last month, the company received
A Director at Inovio Pharmaceuticals (NASDAQ: INO) is Buying Shares
Today, a Director at Inovio Pharmaceuticals (NASDAQ: INO), Morton Collins, bought shares of INO for $133.1K. In addition to Morton